Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Adagio Medical Holdings (ADGM) Accumulated Depreciation & Amortization (2023 - 2026)

Adagio Medical Holdings has reported Accumulated Depreciation & Amortization over the past 4 years, most recently at $2.8 million for Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization fell 6.62% to $2.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Mar 2026, down 6.62% year-over-year, with the annual reading at $2.6 million for FY2025, 2.97% down from the prior year.
  • Accumulated Depreciation & Amortization was $2.8 million for Q1 2026 at Adagio Medical Holdings, up from $2.6 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $3.4 million in Q2 2025 and troughed at $1.8 million in Q4 2023.
  • The 4-year median for Accumulated Depreciation & Amortization is $2.7 million (2024), against an average of $2.7 million.
  • Year-over-year, Accumulated Depreciation & Amortization surged 53.63% in 2024 and then decreased 10.77% in 2025.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $1.8 million in 2023, then skyrocketed by 53.63% to $2.7 million in 2024, then fell by 2.97% to $2.6 million in 2025, then increased by 6.49% to $2.8 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Accumulated Depreciation & Amortization are $2.8 million (Q1 2026), $2.6 million (Q4 2025), and $2.3 million (Q3 2025).